back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-06-18 07:45 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,393
+267 vol $5.22 each |
1,035,524 | |
| Filed 2026-06-18 07:44 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,720
+718 vol $9.36 each |
1,035,257 | |
| Older filings | ||||||
| Filed 2026-03-27 15:53 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$282,271
+44,805 vol $6.30 each |
131,403 | |
| Filed 2026-03-27 15:50 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$778,163
+123,518 vol $6.30 each |
1,066,884 | |
| Filed 2026-03-27 15:44 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-145,125.84
-32,686 vol $4.44 each |
86,598 | |
| Filed 2026-03-27 15:37 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$282,847
+44,126 vol $6.41 each |
1,034,539 | |
| Filed 2026-03-27 15:34 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-145,125.84
-32,686 vol $4.44 each |
||
| Filed 2026-03-23 17:27 Tx date 2026-03-19 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
$-1,236,802.84
-161,252 vol $7.67 each |
943,366 | |
| Filed 2026-03-20 15:36 Tx date 2026-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,118
+211 vol $5.30 each |
990,413 | |
| Filed 2026-03-20 15:35 Tx date 2026-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,565
+902 vol $6.17 each |
990,202 | |
| Filed 2025-12-19 14:12 Tx date 2025-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,300
+250 vol $5.20 each |
989,300 | |
| Filed 2025-12-19 14:11 Tx date 2025-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,500
+1,078 vol $6.03 each |
989,050 | |
| Filed 2025-12-10 13:23 Tx date 2025-12-10 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,445
+3,100 vol $5.95 each |
987,972 | |
| Filed 2025-09-17 15:49 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,118
+253 vol $4.42 each |
984,872 | |
| Filed 2025-09-17 15:48 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,565
+871 vol $6.39 each |
984,619 | |
| Filed 2025-07-11 16:39 Tx date 2025-04-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
$-1,824,820
-182,482 vol $10.00 each |
1,104,618 | |
| Filed 2025-06-18 16:28 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,274
+259 vol $4.92 each |
983,748 | |
| Filed 2025-06-18 16:27 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,402
+1,060 vol $6.04 each |
983,489 | |
| Filed 2025-04-04 19:30 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$119,907
+19,434 vol $6.17 each |
982,429 | |
| Filed 2025-04-04 19:29 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-135,001.52
-25,912 vol $5.21 each |
119,284 | |